Literature DB >> 23008361

Digoxin--'a friend or foe'.

Kolyu Kirov Kolev1.   

Abstract

The authors report about a patient who was admitted after developing nausea, vomiting, change in vision and lethargy. She was on digoxin 250 mcg once daily among all her other medications in the wake of a recent stroke that was accompanied by atrial fibrillation (AF). Her digitalis levels shortly before and on admission were 3.4 and 2.9 ng/ml, respectively. Her admission rhythm was slowly conducted AF at an average of 35 bpm. After a careful assessment by the cardiology consultant in charge, she received Digibind infusion for a chronic digitalis toxicity with the digoxin immune Fab dose based on the formula recommended in the product literature.(3) A few days observation on the ward ensured that her resting heart rate rose to 65 bpm and that she did not need a pacemaker for a slow AF. Her functional status remained reasonably good as she enjoyed a satisfactory recovery postthrombolysis for her recent stroke.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23008361      PMCID: PMC4542954          DOI: 10.1136/bcr.01.2012.5582

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  3 in total

1.  Hyperkalemia in acute digitalis poisoning: prognostic significance and therapeutic implications.

Authors:  C Bismuth; M Gaultier; F Conso; M L Efthymiou
Journal:  Clin Toxicol       Date:  1973       Impact factor: 4.467

2.  Serum digoxin levels and mortality in 5,100 patients.

Authors:  G J Ordog; S Benaron; V Bhasin; J Wasserberger; S Balasubramanium
Journal:  Ann Emerg Med       Date:  1987-01       Impact factor: 5.721

3.  Allergic histories and reactions of patients treated with digoxin immune Fab (ovine) antibody. The Digibind Study Advisory Panel.

Authors:  C H Kirkpatrick
Journal:  Am J Emerg Med       Date:  1991-03       Impact factor: 2.469

  3 in total
  1 in total

1.  Of little yellow men and a fear of the light.

Authors:  Kushal Naha; G Vivek; Ranjan K Shetty; Barkur Ananthakrishna Shastry
Journal:  BMJ Case Rep       Date:  2013-08-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.